Insider Buying: Surgery Partners, Inc. (NASDAQ:SGRY) Director Buys $245,000.00 in Stock

Surgery Partners, Inc. (NASDAQ:SGRYGet Rating) Director Brent Turner purchased 10,000 shares of the business’s stock in a transaction that occurred on Monday, November 21st. The stock was acquired at an average price of $24.50 per share, for a total transaction of $245,000.00. Following the acquisition, the director now directly owns 57,701 shares of the company’s stock, valued at approximately $1,413,674.50. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website.

Surgery Partners Trading Up 6.8 %

SGRY stock opened at $27.49 on Friday. Surgery Partners, Inc. has a twelve month low of $20.46 and a twelve month high of $63.87. The company has a debt-to-equity ratio of 1.47, a current ratio of 1.18 and a quick ratio of 1.07. The firm has a 50 day simple moving average of $26.02 and a 200-day simple moving average of $31.61.

Analyst Ratings Changes

A number of research firms have recently issued reports on SGRY. Royal Bank of Canada dropped their price objective on shares of Surgery Partners from $58.00 to $48.00 and set an “outperform” rating on the stock in a research note on Wednesday. Cowen dropped their price objective on shares of Surgery Partners to $35.00 in a research note on Wednesday, November 16th. StockNews.com lowered shares of Surgery Partners from a “hold” rating to a “sell” rating in a research note on Saturday, November 5th. Citigroup dropped their price objective on shares of Surgery Partners from $49.00 to $38.00 and set a “buy” rating on the stock in a research note on Wednesday, November 9th. Finally, SVB Leerink dropped their price objective on shares of Surgery Partners from $55.00 to $40.00 and set an “outperform” rating on the stock in a research note on Tuesday. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $47.00.

Institutional Trading of Surgery Partners

A number of hedge funds have recently made changes to their positions in SGRY. Mount Yale Investment Advisors LLC acquired a new stake in shares of Surgery Partners during the first quarter worth approximately $246,000. Arizona State Retirement System boosted its holdings in Surgery Partners by 7.7% in the first quarter. Arizona State Retirement System now owns 9,562 shares of the company’s stock worth $526,000 after purchasing an additional 682 shares during the period. Envestnet Asset Management Inc. boosted its holdings in Surgery Partners by 19.9% in the first quarter. Envestnet Asset Management Inc. now owns 11,815 shares of the company’s stock worth $650,000 after purchasing an additional 1,962 shares during the period. Advisor Group Holdings Inc. boosted its holdings in Surgery Partners by 1,468.8% in the first quarter. Advisor Group Holdings Inc. now owns 13,507 shares of the company’s stock worth $1,225,000 after purchasing an additional 12,646 shares during the period. Finally, New York State Common Retirement Fund boosted its holdings in Surgery Partners by 10.7% in the first quarter. New York State Common Retirement Fund now owns 25,309 shares of the company’s stock worth $1,393,000 after purchasing an additional 2,450 shares during the period.

About Surgery Partners

(Get Rating)

Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.

Recommended Stories

Insider Buying and Selling by Quarter for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.